Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from North India
Pankaj Malhotra(Post Graduate Institute of Medical Education and Research), Subhash Varma(Post Graduate Institute of Medical Education and Research), Alka Khadwal(Post Graduate Institute of Medical Education and Research), Deepesh Lad(Post Graduate Institute of Medical Education and Research), Uday Yanamandra(Army Hospital Research and Referral), Arjun Law(Princess Margaret Cancer Centre), Reena Das(Post Graduate Institute of Medical Education and Research), Harshit Khurana(Command Hospital Air Force), Meenakshi Sachdeva(Post Graduate Institute of Medical Education and Research), Neelam Varma(Post Graduate Institute of Medical Education and Research), Praveen Bose(Post Graduate Institute of Medical Education and Research), Gaurav Prakash(Post Graduate Institute of Medical Education and Research)
Cited by 30
Related Papers
Global Burden of Multiple Myeloma
|JAMA Oncology|2018|631
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
|Oncotarget|2017|187
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
|Biology of Blood and Marrow Transplantation|2018|92
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD
|Bone Marrow Transplantation|2020|59
Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats
|Journal of Clinical Medicine|2019|58